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Abstract
Background: The association between premature ovarian failure (POF) and the FMR1 repeat
number (41> CGGn< 200) has been widely investigated. Current findings suggest that the risk
estimation for POF can be calculated in the offspring of women with pre-mutated FMR1 alleles.
Case presentation: We describe the coexistence in a large Italian kindred of Fragile X syndrome
and familial POF in females with ovarian dysfunctions who carried normal or expanded FMR1
alleles. Genetic analysis of the FMR1 gene in over three generations of females revealed that six
carried pre-mutated alleles (61–200), of which two were also affected by POF. However a young
woman, who presented a severe ovarian failure with early onset, carried normal FMR1 alleles (<40).
The coexistence within the same family of two dysfunctional ovarian conditions, one FMR1-related
and one not FMR1-related, suggests that the complexity of familial POF conditions is larger than
expected.
Conclusion: Our case study represents a helpful observation and will provide familial cases with
heterogeneous etiology that could be further studied when candidate genes in addition to the FMR1
premutation will be available.
Background
Premature ovarian failure [POF (MIM 311360)] is an early
ovarian dysfunction characterized by cessation of men-
struation before the age of 40 years [1]. About one in every
1,000 women between the ages of 15–29 and one in every
100 women between the ages of 30–39 are affected by
POF [2]. The aetiology of this disorder is complex and the
underlying genetic defects are largely unknown. Studies of
pedigrees with a familial history of POF suggest that this
condition may be inherited as an autosomal dominant
sex-limited transmission or X-linked with incomplete
penetrance [3-5]. It has been estimated that ~21% of
familial POF cases are associated with expanded alleles of
the  Fragile X mental retardation [FMR1, FXS (MIM
309550)] gene [6-8].
FMR1 is located at Xq27.3 and represents a dynamic
mutational site because an unstable expansion of a trinu-
cleotide (CGG)n repeat occurs at the 5' UTR of the gene
[9]. Based on the number of repeats, four types of FMR1
alleles have been identified: 1) normal, ranging from 6 to
40; 2) grey-zone, from 41 to 60; 3) pre-mutated, from 61
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to 200; and full mutation, exceeding 200. Once the FMR1
allele is fully mutated, hypermethylation of a nearby CpG
island is triggered leading to transcriptional silencing of
FMR1 [10]. This condition causes Fragile X mental retar-
dation, a syndrome with macro-orchidism and behav-
ioural abnormalities that is the most common form of
inherited mental handicap in males.
Intermediate and pre-mutated FMR1 alleles may become
unstable generating a full mutation with further expan-
sion in the following generations, when passed from a
female to her offspring [11]. Such females, also called
Fragile X intermediate or pre-mutation carriers, are phe-
notypically normal although with an increased risk of
POF [8,12]. Firm evidences exist for a significant associa-
tion between FMR1 allele size and the age of menopause
among POF females [7,8]. These studies allow improved
risk assessments for the genetic counselling of familial
POF manifestations where women present pre-mutated
FMR1 alleles [12].
The aim of this study is to present a large pedigree in
which two different POF disorders coexist, one FMR1-
related and one not FMR1-related.
Case presentation
Case history
A large Italian three-generation kindred was brought to
our attention because its members were affected by POF
manifestations and FRAXA syndrome (Figure 1). All will-
ing family members provided written informed consent
under protocols approved by Declaration of Helsinki.
They were examined and classified as part of an ongoing
genetic study of ovarian X-linked dysfunction. A system-
atic interview was conducted with thirteen family mem-
bers.
According to common protocol, POF status was defined
as hypergonadotrophic amenorrhoea with FSH measure-
ments ≥ 20 IU, LH > 15 IU and cessation of menses for a
duration of ≥ 6 months, at age ≤ 40 years.
The proband girl (IV:7), a 24-year-old girl, was referred
because of ovarian failure with hypergonadotropic amen-
orrhea consistent with a diagnosis of POF (FSH measure-
ment = 102,00 mIU/ml, LH measurement = 18,00 mIU/
ml). She had a menarche at 13 years of age and had always
irregular menstrual cycles until the age of 18 years when
she entered menopause. Her condition was considered
idiopathic because she did not show any of the known
POF-related conditions such as ovarian surgery, previous
chemotherapy or radiotherapy, or autoimmune disease.
Pelvic ultrasonography and laparoscopic ovarian biopsies
were performed. Both examinations revealed the com-
plete absence of follicles consistent with a diagnosis of
POF type B [13]. Cytogenetic analysis demonstrated that
she was a carrier of an inversion of chromosome 2, with
kariotype 46, XX inv(2)(p12q13) (data not shown). To
our knowledge, this is a constitutional pericentric variant
of chromosome 2, which originated through inversion
between two chromosomal breakpoints, conserved in pri-
mates [14]. Furthermore, 2p12 and 2q13 are well known
as fragile sites (FRA2L, FRA2A, FRA2B; [15]) reflecting the
break-prone nature of the pericentromeric region of chro-
mosome 2.
The female III:3 (age 49), mother of the case study, who
entered menopause at 45 years, had no symptoms of POF
disorder. She had a karyotype with 46, XX
inv(2)(p12q13), the same inversion observed in the
proband IV:7. The female IV:5 (age 25), the sister of the
proband IV:7, had regular menses and a normal karyo-
type. Their maternal grandmother (II:2, age 75) had five
daughters and underwent a hysterectomy at age 47
because she was affected by diffuse fibromatosis of the
uterus. The female II:3 (age 65) had two sons (III:6 and
III:7) and similarly to her sister (II:2) underwent at hyster-
ectomy at age 46. Both II:6 (age 60) and III:9 (age 47),
that are respectively the great-aunt and the aunt of the
proband, suffered from a POF syndrome with amenor-
rhoea at age 35. The female III:10 (age 46), daughter and
sister of the two POF females (II:6 and III:9, respectively)
had no symptoms of premature menopause. She had two
children, a 11-year-old daughter, IV:13, that was in pre-
pubertal age and a young-boy of 6 years old, IV:15, with
Fragile X syndrome showing severe mental retardation,
behavioural problems and macroorchidism.
As referred to us, the remaining at risk females III:4 (age
38), III:5 (age 35), III:6 (age 36) had regular menses and
did not suffer from POF symptoms. In one of them, III:5,
the inversion of chromosome 2, inv(2)(p12q13), already
present in III:3 and IV:7, was found. Regarding the
females III:1 (age 57) and III:2 (age 50), both had an
apparently regular fertility life and entered menopause at
age 51 and 50, respectively. Spontaneous miscarriages
were reported for several women (III:2, III:3, III:6) as
shown in Figure 1. Unfortunately, a definite cause has
been difficult to determine in each of these cases even if
an association between infertility and spontaneous abor-
tion has been proposed [16].
Case analysis
FMR1 genotype repeat size
Genomic DNA was isolated from 10 ml of the peripheral
blood samples in an EDTA tube, using standard proce-
dures [17]. The FMR1 repeat length was determined in the
family under study by fluorescent polymerase chain reac-
tion (PCR) amplification and electrophoresis analysis onBMC Medical Genetics 2007, 8:18 http://www.biomedcentral.com/1471-2350/8/18
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an automatic sequencer (ABI PRISM 3100, Applied Bio-
system, Foster City, CA, USA). "C" and "F" primers used
for the FMR1 gene amplification were described in Fu et
al. (1991) [18]. The results were elaborated with Genescan
3.1 software. To validate the mutated alleles previously
detected by PCR, genomic DNA was digested with EcoRI
and EagI, blotted onto Hybond N+ (Amersham, Milan,
Italy) and thus hybridised to the probe StB 12.3, as previ-
ously described [19].
X-chromosome inactivation, XCI
The XCI ratio was determined by methylation-sensitive
restriction enzyme digestion of genomic DNA followed by
PCR amplification and product quantification on an auto-
matic sequencer. Digested and undigested samples were
then amplified at the AR locus. The protocol was carried
out as previously described [5].
Results and discussion
In a large Italian kindred with a family history of POF and
FRAXA disorders two different dysfunctional ovarian con-
ditions are present, one FMR1-related and one not FMR1-
related (Figure 1). The proband IV:7, is a young woman
with severe POF disease as described above. Because of the
presence in the family of a young-boy (IV:15) with Mar-
tin-Bell syndrome (MIM300624), we started our analysis
establishing the segregation of FMR1 expanded alleles in
the family. As expected, IV:15 had a FRAXA syndrome
with an FMR1 full mutation with 630 repeats of the tri-
nucleotide CGG. In consequences of this, an FMR1 study
was carried out on the females related to him, either with
POF manifestations (II:6, III:9, IV:7) or at risk but with
regular ovarian functions (II:2, III:3; III:5, III:6, III:10,
IV:5, IV:13).
Both mother and sister of the FRAXA male, III:10 and
IV:13, carried pre-mutated FMR1 alleles. III:10 was 28/
100 CGG repeat allele and IV:13 was 27/200 CGG repeat
allele; while a normal brother (IV:14) carried a hemizy-
gote 28 CGG repeat allele. His maternal grandmother
(II:6) and maternal aunt (III:9), both affected with POF,
were heterozygotes for premutated alleles with 27/200
and 28/200 repeat alleles, respectively.
In the mother-daughter transmission (II:6-III:10), the
presence in III:10 of the FMR1 allele with 100 CGG repeat
could be the result of a backward mutation or contraction
upon transmission from the mother with 200 CGG allele.
This phenomenon is the product of the high instability of
the FMR1 CGG repeats that was found to increase with
increasing of the repeat length and that, generally, occurs
with higher frequency in the paternal transmission than
in maternal transmission [12,20,21].
The female IV:7 (the proband) had a POF diagnosis and
she was the second cousin of the FRAXA male. Therefore,
we extended the FMR1 analysis to her familial unit. In
spite of the association between POF disease and FMR1
expanded alleles that was ascertained in the family, the
genotype of the POF IV:7 was not in agreement with this
status. Indeed, she carried two normal FMR1 alleles, one
of 30 repeats and one of 31 repeats. Her mother (III:3)
and sister (IV:5), both with no symptoms of ovarian dys-
function, were heterozygotes with normal FMR1 alleles,
Genealogical tree of Family #_P1 presenting POF manifestation, FRAXA disorder and FMR1 premutated and mutated alleles Figure 1
Genealogical tree of Family #_P1 presenting POF manifestation, FRAXA disorder and FMR1 premutated and mutated alleles. 
With F the genotypes of FMR1 alleles obtained by PCR and Southern blot assays are shown.BMC Medical Genetics 2007, 8:18 http://www.biomedcentral.com/1471-2350/8/18
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29/31 and 30/31, respectively. In contrast, her maternal
grandmother (II:2) who did not have ascertained ovarian
failure, carried a premutated allele with the genotype 31/
100. Similarly, the aunt of the proband (IV:7), one of the
daughters of II:2 who reported no history of POF, was het-
erozygote for premutated CGG repeats with 24/200 alle-
les. Another type of analysis that can give further
information on the involvement of the premutated FMR1
gene in POF manifestation may be represented by X-inac-
tivation studies because FMR1-related POF severity may
be dictated by X-inactivation pattern [22]. Evaluation of X
chromosome inactivation (XCI) status in the peripheral
blood of the POF and risk females with normal and/or
expanded FMR1 alleles revealed that the XCI pattern is
random (data not shown). Moreover, X-inactivation was
measured in cells of the blood where its status may be dif-
ferent in the ovarian tissue.
Based on these evidences, we assumed that in this family
different factors concur to cause ovarian dysfunction: one
factor is the instability of FRAXA alleles, an ascertained
risk factor for the females with POF, II:6 and III:9; while
an other unknown factor could operate in the young
female IV:7 causing severe ovarian failure. We are unable
to pinpoint exactly what the relationship is between these
different conditions and how they may influence normal
ovarian function.
In our opinion and accordingly to several reports [1-6,21],
POF disorders should be considered as multifactorial dis-
eases and in view of this, studying the phenotypical and
genetic features of new cases could contribute to the shed-
ding of new light on the great complexity of POF.
In conclusion, our case report represents an original
observation on the coexistence within one family of dif-
ferent factors involved in two different ovarian failure
conditions, one-FMR1 related and one not-FMR1 related.
On the other hand, it can be considered an important
warning for the genetic counselling of familial POF. In
particular, we believe that the association of POF with
expanded FMR1 alleles must be verified through the gen-
erations allowing the clinical counselling of familial POF
and eventually the implementation of strategies to
advance conception.
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